Assessment of quality of life: Advantages and pitfalls

Clinical and Experimental Allergy Reviews

Volumn 5, Issue 1, 2005, Pages 32-35

  Van Wijk, R Gerth ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Allergic rhinitis; Asthma; Health related quality of life; Pediatric Allergic Disease Quality of Life Questionnaire (PADQOLQ); RHINASTHMA; Short form 36 (SF 36)

Indexed keywords

ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY TEST; ANAMNESIS; ASTHMA; ECONOMIC EVALUATION; HUMAN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SHORT FORM 36; VALIDATION PROCESS;

EID: 22844449665     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.0080.x     Document Type: Review

References (18)

1. Testa MA and Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334:835-40.
2. Gerth van Wijk R. Allergy: a global problem. Quality of life. Allergy 2002; 57:1097-10.
3. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, ed. Quality of life assessment in clinical trials. New York: Raven Press, 1990; 11-24.
4. Juniper EF. Can quality of life be quantified? Clin Exp Allergy Rev 2002; 2:57-60.
5. Bousquet J, van Cauwenberge P, Khaltaev N. ARIA Workshop Group, WHO. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl.):S147-334.
6. Bousquet J. Is the impairment of quality of life acceptable for the patient? Clin Exp Allergy Rev 2002; 2:61-65.
7. Bousquet J, Duchateau J, Pignat JC et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis, as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996; 98:309-16.
8. Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol 2003; 111:491-7.
9. Baiardini I, Pasquali M, Giardini A et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003; 58:289-94.
10. de Graaf-in't Veld T, Koenders S, Garrelds IM, Gerth van Wijk R. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996; 98:508-13.
11. Juniper EF, Price DB, Stampone PA, Creemers JPHM, Mol SJM, Fireman P. Clinically important improvements in asthma-specific quality of life, but no differences in conventional indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002; 121:1824-32.
12. Kremer B, Klimek L, Bullinger M, Mösges R. Generic or disease-specific quality of life scales to characterise health status in allergic rhinitis? Allergy 2001; 56:957-63.
13. Groenewoud GCM, de Jong NW, van Oorschot-van Nes AJ et al. Prevalence of occupational allergy to bell pepper pollen in greenhouses in the Netherlands. Clin Exp Allergy 2002; 32:434-40.
14. Groenewoud GCM, de Graaf in't Veld C, van Oorschot-van Nes AJ et al. Prevalence of sensitization to the predatory mite Amblyseius cucumeris as a new occupational allergen in horticulture. Allergy 2002; 57:614-19.
15. Bousquet J, Lund VJ, van Cauwenberge P et al. Implementation of guidelines for seasonal allergic rhinitis: a randomised controlled trial. Allergy 2003; 58:733-41.
16. Noonan MJ, Raphael GD, Nayak A et al. The health-related quality of life effects of once-daily cetirizine HCL in patients with seasonal allergic rhinitis: a randomised double-blind, placebo-controlled trial. Clin Exp Allergy 2003; 33:351-8.
17. Casale TB, Condemi J, LaForce C et al. Effect of Omalizumab on symptoms of seasonal allergic rhinitis. A randomized controlled trial. JAMA 2001; 286:2956-67.
18. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardised version of the rhinoconjunctivitis quality of life questionnaire. J Allergy Clin Immunol 1999; 104:364-9.